RELAY THERAPEUTICS INC
NASDAQ: RLAY (Relay Therapeutics, Inc.)
Kemas kini terakhir: 18 jam lalu14.81
0.57 (4.00%)
| Penutupan Terdahulu | 14.24 |
| Buka | 14.21 |
| Jumlah Dagangan | 1,770,119 |
| Purata Dagangan (3B) | 3,707,147 |
| Modal Pasaran | 3,227,696,384 |
| Harga / Jualan (P/S) | 241.55 |
| Harga / Buku (P/B) | 5.02 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -1,105.21% |
| EPS Cair (TTM) | -2.20 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -23.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.54% |
| Nisbah Semasa (MRQ) | 19.96 |
| Aliran Tunai Operasi (OCF TTM) | -271.99 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -155.22 M |
| Pulangan Atas Aset (ROA TTM) | -28.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -45.46% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Relay Therapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.13 |
|
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.48% |
| % Dimiliki oleh Institusi | 105.68% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Nextech Invest, Ltd. | 31 Mar 2026 | 5,526,506 |
| Spruce Street Capital Lp | 31 Mar 2026 | 2,984,125 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |